HAWC vs RevMan

HAWC is a free web application for storing, displaying, and synthesizing data used in human health and environmental risk assessments. Its modules support study-quality evaluation, data extraction from human epidemiology, animal bioassay, and in vitro studies, evidence synthesis, and dose-response analysis. Assessment teams can assign managers, members, and reviewers role-based permissions for viewing, editing, and administration. Published material is viewable without an account, while collaboration on an ongoing assessment with EPA scientists requires a Login.gov account and approved EPA HAWC group access. Interactive visualizations connect studies, experiments, endpoints, and dose information. Users can download available datasets as Microsoft Excel files and export figures to PDF or other formats. Benchmark dose modeling is performed endpoint by endpoint at the EPA HAWC chemical manager’s discretion. HAWC supports most modern browsers, with Google Chrome preferred, and reports functionality errors with Internet Explorer.

RevMan is Cochrane’s software for building systematic reviews, from structured data entry and analysis to presenting results. It supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. Authors can edit separate parts of a review at the same time and see who else is working on it. Analysis options include pairwise meta-analyses, sensitivity and subgroup analyses, and fixed-effects, random-effects, Mantel-Haenszel, and inverse-variance models. Built-in outputs include forest, SROC, and funnel plots, risk-of-bias assessments, and PRISMA flow diagrams. Authors can work from ready-made or custom templates and structured headings with Cochrane methodological guidance. RevMan imports study data and references from Covidence, and RIS reference imports can draw on Crossref, PubMed, or CRS. A free practice review is deleted after 30 days and permits one person, with no data export. Free access is also available to authors working on Cochrane Reviews. Individual annual plans are £80 a year for eligible students, £100 a year for eligible academics, and £130 a year for standard subscriptions; VAT applies in the EU and UK.